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        Bronchial asthma is a heterogeneous syndrome 
associated with diverse factors, including al-
lergen sensitization, infection, obesity, as well 
as exposure to air pollution (  1  ). Regardless of 
the trigger, asthma is associated with reversible 
airway obstruction and airway hyperreactivity 
(AHR) and an increased sensitivity of the air-
ways to nonspecifi  c stimuli such as cold air or 
respiratory irritants, and quantitated by respon-
siveness to methacholine or histamine (  2  ). Di-
verse mechanisms have been proposed to explain 
the pathogenesis of various asthma phenotypes, 
including allergic infl  ammation, Th2 cells, eo-
sinophils, basophils (  3  ), neutrophils (  4  ), and oxi-
dative stress (  5  ). Thus, diff  erent forms of asthma 
appear to depend on distinct cell types and path-
ways, and a shared disease mechanism for all 
forms of asthma has not been established. 
  Invariant TCR natural killer T (  i  NKT) cells 
comprise a newly described, unique subset of 
lymphocytes that express features of both classical 
T cells and NK cells.   i  NKT cells express a con-
served/invariant TCR repertoire consisting of 
V    14-J    18 (in mice) or V    24-J    18 (in humans) 
(  6  ).   i  NKT cells are activated by recognition of 
glycolipid antigens presented by the nonpoly-
morphic MHC class I  –  like protein CD1d, which 
is widely expressed by airway and intestinal epi-
thelial cells, B cells, macrophages, and dendritic 
cells. Recognition of CD1d-presented glycolip-
ids by   i  NKT cells is highly conserved across phy-
logeny, suggesting that   i  NKT cells play a pivotal 
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  Exposure to ozone, which is a major component of air pollution, induces a form of asthma 
that occurs in the absence of adaptive immunity. Although ozone-induced asthma is char-
acterized by airway neutrophilia, and not eosinophilia, it is nevertheless associated with 
airway hyperreactivity (AHR), which is a cardinal feature of asthma. Because AHR induced 
by allergens requires the presence of natural killer T (NKT) cells, we asked whether ozone-
induced AHR had similar requirements. We found that repeated exposure of wild-type (WT) 
mice to ozone induced severe AHR associated with an increase in airway NKT cells, neutro-
phils, and macrophages. Surprisingly, NKT cell  –  defi  cient (CD1d       /       and J     18       /      ) mice failed 
to develop ozone-induced AHR. Further, treatment of WT mice with an anti-CD1d mAb 
blocked NKT cell activation and prevented ozone-induced AHR. Moreover, ozone-induced, 
but not allergen-induced, AHR was associated with NKT cells producing interleukin (IL)-17, 
and failed to occur in IL-17       /       mice nor in WT mice treated with anti  –  IL-17 mAb. Thus, 
ozone exposure induces AHR that requires the presence of NKT cells and IL-17 production. 
Because NKT cells are required for the development of two very disparate forms of AHR 
(ozone- and allergen-induced), our results strongly suggest that NKT cells mediate a unifying 
pathogenic mechanism for several distinct forms of asthma, and represent a unique target 
for effective asthma therapy. 386 OZONE-INDUCED AHR REQUIRES NKT CELLS AND IL-17 | Pichavant et al.
that maximized airway infl  ammatory cell recruitment over a 
brief period of time. Exposure of WT BALB/c mice to ozone 
in this manner resulted in higher baseline airway resistance, 
and in the development of severe AHR (  Fig. 1 A  ) and sig-
nifi  cant airway infl  ammation, consisting of increased macro-
phages, lymphocytes, and neutrophils, but not eosinophils, in 
the bronchoalveolar lavage (BAL) fl  uid (  Fig. 1 C  ).   Repeated 
ozone exposure also increased the number of   i  NKT cells in 
the BAL fl  uid by   >  10-fold (  Fig. 1 D  , and Fig. S1, available 
at http://www.jem.org/cgi/content/full/jem.20071507/DC1). 
To determine the role of these   i  NKT cells in the develop-
ment of AHR, we compared WT mice and CD1d      /      mice, 
which lack the restriction element of NKT cells, and there-
fore lack NKT cells (  6  ). Surprisingly, CD1d      /      mice exposed 
to ozone failed to develop AHR (  Fig. 1 A  ). The CD1d      /      
mice exposed to repeated ozone exposure also had fewer 
role in immunity (  7, 8  ). Activation of   i  NKT cells results in an 
innate-like immune response, with rapid production of large 
quantities of cytokines, including IL-4 and IFN-     (  6, 9  ), and 
this rapid response endows   i  NKT cells with the capacity to crit-
ically amplify adaptive immunity and regulate the development 
of polarized T cells. The rapid production of cytokines by 
  i  NKT cells has been shown to regulate the development of 
several diseases, including diabetes mellitus, colitis, autoimmune 
neurological disease, rejection of malignant tumors, infectious 
diseases, and asthma (  10  –  14  ). 
  In animal models of allergic asthma,   i  NKT cell  –  defi  cient 
mice (CD1d      /      or J    18      /      mice) fail to develop AHR when 
sensitized and challenged with allergens (  13, 14  ). This require-
ment for   i  NKT cells in the development of allergen-induced 
AHR is independent of Th2 responses, which develop normally 
in these mice (  15  ). The requirement for   i  NKT cells is also spe-
cifi  c because adoptive transfer of WT   i  NKT cells reconstituted 
the capacity of J    18      /      mice to develop AHR. Furthermore, 
direct activation of   i  NKT cells by the respiratory administration 
of glycolipids such as     -Galactosylceramide (    -GalCer) or 
glycolipids isolated from   Sphingomonas   bacteria caused AHR and 
airway infl  ammation, even in the complete absence of class II 
MHC  –  restricted T cells and adaptive immunity (  16  ). More-
over,   i  NKT cells are present in the lungs of patients with asthma 
(  17  –  19  ), although the specifi  c factors that regulate their fre-
quency and function in the lungs has not been fully established. 
Together, these studies suggest that   i  NKT cells play a very im-
portant role in the development of asthma and AHR. 
  To determine whether   i  NKT cells form the basis for a 
shared pathogenic mechanism for diff  erent forms of asthma, 
we examined the role of   i  NKT cells in a form of AHR not 
thought to involve immune mechanisms, i.e., that induced 
by exposure to ozone, a major component of air pollution. 
In children, ambient exposure to ozone increases asthmatic 
symptoms even at concentrations below the U.S. Environ-
mental Protection Agency standard (  20  ), and hospital admis-
sions for asthma are higher on days of high ambient ozone 
concentrations (  21, 22  ). Even in healthy individuals, expo-
sure to ozone induces the development of AHR that is asso-
ciated with airway epithelial cell damage and an increase in 
neutrophils and infl  ammatory mediators (TNF-    , CXCL-8/
IL-8, IL-6, and GM-CSF) in proximal airways (  23, 24  ), and 
asthmatics appear to be more susceptible to the adverse eff  ects 
of this pollutant (  25  ). In our current studies, we demonstrated 
that repeated exposure of mice to ozone induced AHR that 
required the presence of   i  NKT cells and the production of 
IL-17, which is a potent neutrophil chemotactic factor. These 
results suggest that innate immunity involving   i  NKT cells 
may play a critical role as a unifying pathogenic mechanism 
for several very distinct forms of asthma. 
    RESULTS   
  NKT cells are required for AHR induced by repeated
ozone exposure 
  We exposed mice to ozone (1 part per million [ppm] for 3 h) 
every other day over a 5-d period, using a semiacute protocol 
    Figure 1.     Ozone exposure induces AHR and increases airway 
infl  ammation in WT, but not in CD1d       /      , mice.     WT BALB/c mice and 
NKT  cell – defi  cient CD1d     /     mice were exposed 3 times to 1 ppm of ozone 
over 5 d or to room air. (A) Changes in lung resistance (R  L  ) were measured 
in anesthetized, tracheotomized, intubated, and mechanically ventilated 
mice. Ozone exposure induces an increase in AHR in WT, but not in 
CD1d     /    , mice. (B) WT BALB/c and CD1d     /     mice were exposed to ozone 
as in A, and treated with anti-CD1d blocking mAb or isotype control mAb. 
Ozone-induced AHR was prevented by the anti-CD1d mAb treatment. 
(C) BAL fl  uid was collected 24 h after the last ozone challenge of mice 
depicted in A and B. Total and differential cell counts were evaluated in 
BAL fl  uid. Ozone exposure induced pulmonary infl  ammation associated 
with neutrophils, which was reduced by treatment with anti-CD1d mAb 
and in CD1d     /     mice. The inset is a magnifi  cation of the data for lympho-
cytes and neutrophils. (D) Ozone exposure increased the number of   i NKT 
cells in BAL fl  uid of WT, but not CD1d     /    , mice. Anti-CD1d mAb treatment 
decreased the number of   i  NKT cells in BAL fl  uid after ozone exposure. 
  i  NKT cells were identifi  ed by staining with CD1d tetramers loaded with 
PBS57 (or with empty CD1d tetramers as control) and anti-TCR     mAb. 
Results are expressed as the mean   ±   the SEM. P   ≤   0.05 (*) and P   ≤   0.01 (**) 
compared with mice exposed to air. These results represent one out of 
four experiments, with fi  ve mice in each group.     JEM VOL. 205, February 18, 2008 
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to ozone and found that the IL-17  –  producing T cells were 
NK1.1        (  Fig. 3 C  ). This suggests that the IL-17  –  producing 
  i  NKT cells induced with ozone were distinct from the IL-4/
IL-13  –  producing   i  NKT cells, which are generally NK1.1  +  , 
at least in C57BL/6 mice. 
  To determine whether the development of ozone-induced 
AHR required IL-17 production by conventional CD4  +   
T cells (Th17 cells) or by   i  NKT cells, we exposed MHC class 
II      /      mice, which lack conventional CD4  +   T cells but have 
  i  NKT cells, to ozone.   Fig. 3 B   shows that the MHC class 
II      /      mice developed severe ozone-induced AHR and se-
vere airway infl  ammation (not depicted), as did the WT mice 
exposed to ozone. These results clearly indicated that IL-17  –
  producing   i  NKT cells and not Th17 cells are required for 
the development of ozone-induced AHR, although it is 
possible that Th17 cells may contribute to the development 
of AHR. 
  Ozone-induced, but not allergen-induced, AHR
requires IL-17 
  Importantly, IL-17 production in the lungs was absolutely 
required for ozone-induced AHR because treatment of mice 
airway macrophages, and signifi  cantly less airway lympho-
cytes and neutrophils in BAL fl  uid compared with that of 
WT mice (  Fig. 1 C  ). The requirement for   i  NKT cells was 
not dependent on the genetic background of our mice (all 
backcrossed to BALB/c), as we observed the same eff  ects 
in C57BL/6 mice (unpublished data). Pretreatment of WT 
mice with an anti-CD1d  –  blocking mAb to prevent   i  NKT 
cell activation also reduced ozone-induced AHR (  Fig. 1 B  ), 
and decreased the number of lymphocytes, neutrophils, and 
  i  NKT cell numbers in the BAL fl  uid (  Fig. 1, C and D  ). Thus, 
repeated exposure of mice to ozone induced AHR that de-
pended on the presence of CD1d restricted T cells. 
  J     18       /       mice fail to develop ozone-induced AHR 
  To confi  rm that   i  NKT cells were specifi  cally required for the 
development of ozone-induced AHR, we examined another 
  i  NKT cell  –  defi  cient strain, J    18      /      mice, which lack the in-
variant TCR-     chain, and therefore lack   i  NKT cells (  6  ). 
Like CD1d      /      mice, J    18      /      mice repeatedly exposed to 
ozone over 5 d failed to develop AHR, whereas WT mice 
exposed to ozone developed severe AHR (  Fig. 2 A  ).   Com-
pared with WT mice, J    18      /      mice exposed to ozone also 
had signifi  cantly reduced numbers of airway macrophages, 
lymphocytes, and neutrophils (  Fig. 2 B  ) and no detectable 
  i  NKT cells (  Fig. 2 C  ) in BAL fl  uid. The specifi  c requirement 
for   i  NKT cells in the development of ozone-induced AHR 
was demonstrated by adoptive transfer of purifi  ed WT   i  NKT 
cells into J    18      /      mice, which partially restored the capacity 
of J    18      /      mice to develop ozone-induced AHR (  Fig. 2 D  ). 
Full restoration of the AHR response was not achieved by 
adoptive transfer of WT   i  NKT cells, presumably because in-
suffi   cient numbers of   i  NKT cells migrated into the lungs of 
recipients (the number of   i  NKT cells in the BAL fl  uid of re-
cipients was only 30% of that found in WT mice; unpub-
lished data). 
  IL-17 is required for ozone-induced neutrophilia and AHR 
  Because ozone-induced AHR was associated with airway 
neutrophilia, we evaluated the role of IL-17, which has been 
shown to enhance neutrophil migration to sites of infl  amma-
tion (  26, 27  ). We found that repeated ozone exposure was 
associated with the induction of IL-17 synthesis in   i  NKT 
cells and small numbers of T cells in the lungs (  Fig. 3 A  ), but 
not in the spleen (not depicted).   Note that the total number 
of cells in the lungs was greatly increased after ozone treat-
ment (three- to sixfold), and therefore the percentages of cells 
indicated by fl  ow cytometry underestimated the increases in 
IL-17  –  producing cells induced with ozone exposure. In ad-
dition, we found that the pulmonary   i  NKT cells produced 
IL-4, but not IFN-    , unlike resting or activated splenic   i  NKT 
cells, which produce both IL-4 and IFN-    , suggesting that 
IL-4, but not IFN-    , production by   i  NKT cells also played a 
role in the induction of ozone AHR. Ozone also induced 
IL-10 expression in   i  NKT cells, but not T cells, in the lungs 
(  Fig. 3 A  ). To assess expression of NK1.1 by the iNKT cells 
(not present in BALB/c mice), we exposed C57BL/6 mice 
    Figure 2.     Ozone exposure induces AHR in WT, but not in J     18         /      , 
mice.     WT BALB/c and   i NKT  cell – defi  cient J   18    /     mice were exposed 
3 times to 1 ppm of ozone versus air. (A) Changes in lung resistance (R  L ) 
were measured on anesthetized, tracheotomized, intubated, and mechani-
cally ventilated mice. Ozone exposure induced signifi  cant AHR in WT, but 
not in J   18    /     mice. (B) Total and differential cell counts in BAL fl  uid 
were evaluated. WT, but not J   18    /    , mice develop an increase in the 
number of airway macrophages, lymphocytes, and neutrophils. The insert 
is a magnifi  cation of the data for lymphocytes and neutrophils. (C) Ozone 
exposure increases   i  NKT cell number in BAL fl  uid of WT, but not J   18    /   , 
mice. NKT cells were identifi  ed as described in   Fig. 1 D  . (D) Adoptive transfer 
of WT   i  NKT cells into J   18    /     mice partially restores AHR induced by 
repeated ozone exposure. Results are expressed as the mean   ±   the SEM. 
P   ≤   0.05 (*) and P   ≤   0.01 (**) compared with mice exposed to air. These re-
sults represent one out of four experiments, with fi  ve mice in each group.     388 OZONE-INDUCED AHR REQUIRES NKT CELLS AND IL-17 | Pichavant et al.
the cytokines produced by these cells are distinct, with IL-17 
playing a pathogenic role in ozone-induced, but not allergen-
induced AHR. 
  IL-4 and -13 are also involved in ozone-induced AHR
and airway infl  ammation 
  We previously showed that   i  NKT cells producing IL-4 and 
-13 are essential in the development of allergen-induced 
AHR (  13  ). Because IL-4 was present in most of the   i  NKT 
cells in the lungs of ozone-exposed mice (  Fig. 3  ), we sought 
to determine whether IL-4 and -13 were also required for 
AHR induced by repeated ozone exposure. To that end, we 
exposed IL-4      /     /IL-13      /      double knockout, IL-13      /     , and 
IL-4      /      mice to ozone over a 5-d period. After exposure to 
ozone, the IL-4      /     /IL-13      /      mice failed to develop AHR 
and had reduced airway infl  ammation, including signifi  cantly 
fewer macrophages and lymphocytes, compared with WT 
mice (  Figs. 5, A and B  ).   The requirement of IL-4 and -13 
with an anti  –  IL-17 blocking mAb greatly reduced ozone-
induced AHR (  Fig. 4 A  ), airway lymphocytes, and neutro-
phils (but not macrophages;   Fig. 4 B  ).   These results were 
confi  rmed in IL-17      /      mice, which failed to develop ozone-
induced AHR (  Fig. 4 E  ) and infl  ammation (Fig. S2, available 
at http://www.jem.org/cgi/content/full/jem.20071507/DC1). 
IL-17 production by   i  NKT cells or T cells was required spe-
cifi  cally for ozone-induced, but not allergen-induced, AHR 
because OVA-induced AHR and infl  ammation occurred 
normally in WT mice treated with anti  –  IL-17 blocking mAb 
(  Figs. 4, C and D  ) and in IL-17      /      mice (  Fig. 4 F  ). In addi-
tion, IL-17  –  producing cells were not detected in the lungs 
of mice sensitized and challenged with OVA to induce AHR 
(unpublished data). Therefore, these results demonstrate 
that IL-17 plays a critical role in the development of AHR 
and airway infl  ammation induced by repeated ozone expo-
sure, but not by allergen. Thus, although both allergen- and 
ozone-induced AHR require the presence of   i  NKT cells, 
    Figure 3.       i  NKT cells and T cells produce IL-17 after ozone exposure.   WT BALB/c mice were exposed 3 times to 1 ppm of ozone versus air. Intra-
cellular IL-4, IFN-    , IL-17, and IL-10 staining was performed on T cell  –  enriched lung cells without further stimulation, but treated with GolgiStop for 2 h. 
(A)   i  NKT cells were analyzed by gating on CD1d tetramer  +   TCR   +   cells (top). T cells were analyzed by gating on CD1d tetramer        cells (bottom). The fl  ow 
cytometry data are provided as dot plots. Numbers in each quadrant indicate the percentage of cells in that quadrant. The number of dots (events) is 
much greater for T cells than for   i  NKT cells because the number of NKT cells in the lungs is only a fraction of the number of T cells present. Data are 
representative of three independent experiments. (B) MHC class II     /     mice were exposed to ozone or air. Changes in lung resistance (R  L  ) were measured 
on anesthetized, tracheotomized, intubated, and mechanically ventilated mice. Ozone exposure induced signifi  cant AHR in WT mice and MHC class II     /    
mice. (C) C57BL/6 mice were exposed to ozone.   i  NKT cells in the BAL fl  uid were analyzed by gating on CD1d tetramer  +   TCR   +   cells, and by staining for 
expression of NK1.1 and IL-17. The IL-17  +   cells were NK1.1 negative.     JEM VOL. 205, February 18, 2008 
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diff  er in their requirement for IL-17 and in the types of in-
fl  ammatory cells present in the airways (eosinophils versus 
neutrophils), both forms of AHR require   i  NKT cells pro-
ducing IL-4 and -13. 
    DISCUSSION   
  In this study, we demonstrated that repeated exposure to 
ozone induces AHR mediated by a novel mechanism in-
volving innate-like immunity,   i  NKT cells, and IL-17. Thus, 
  i  NKT cell  –  defi  cient mice, including CD1d      /      and J    18      /      
strains, generated by disruption of two completely indepen-
dent genes failed to develop ozone-induced AHR. Blockade 
production by   i  NKT cells for ozone-induced AHR was con-
fi  rmed by additional studies demonstrating that adoptive 
transfer of   i  NKT cells purifi  ed from IL-4      /     /IL-13      /      dou-
ble knockout mice into J    18      /      mice failed to reconstitute 
ozone-induced AHR (  Fig. 5 C  ), whereas transfer of WT 
  i  NKT cells partially restored AHR (  Fig. 2 D  ). Furthermore, 
IL-13      /      and -4      /      mice exposed to ozone both failed to 
develop AHR (  Figs. 5, D and E  , and Fig. S2). These results 
indicate that although allergen- and ozone-induced AHR 
    Figure 4.     IL-17 is involved in ozone-induced, but not in OVA-
induced, AHR.   (A and B) The response of WT mice to ozone was greatly 
reduced by treatment with anti  –  IL-17 mAb (aIL-17 Ab). WT mice were 
exposed 3 times to 1 ppm ozone versus air and treated with anti  –  IL-17 
blocking mAb or isotype control. (A) Airway responsiveness to metha-
choline was measured in anesthetized, tracheotomized, intubated, and 
mechanically ventilated mice and reported as the percentage of in-
crease in airway resistance. (B) BAL fluid was collected 24 h after the 
last airway challenge. Total and differential cell counts were evaluated. 
Treatment with anti  –  IL-17 reduced airway lymphocytes and neutrophils. 
(C and D) Anti  –  IL-17 Ab treatment does not reduce OVA-induced AHR (C) 
or OVA-induced airway inflammation (D). Mice were sensitized i.p. and 
challenged intranasally with OVA for 3 d, and were treated with anti  –  IL-17 
blocking mAb or isotype control 1 d before the 3 OVA challenges. (D) BAL 
fl  uid was collected and evaluated as in B. Results are expressed as the 
mean   ±   the SEM. P   ≤   0.05 (*) and P   ≤   0.01 (**) compared with untreated mice 
or mice exposed to air. Data are representative of two independent experi-
ments with fi  ve mice in each group. (E) IL-17     /     mice fail to develop ozone-
induced AHR. Mice were treated as in A and B, and examined for AHR. 
(F) IL-17     /     mice develop normal OVA-induced AHR. IL-17     /     mice were 
sensitized and challenged with OVA before examination for AHR by 
challenge with methacholine.     
    Figure 5.     IL-4 and -13 are involved in ozone-induced AHR and 
airway infl  ammation.   WT BALB/c, IL-4     /   /IL-13    /     double-knockout, 
IL-13     /    , and IL-4     /     mice were exposed 3 times to 1 ppm of ozone versus 
air. (A) AHR was measured as in   Fig. 4 A  . IL-4     /   /IL-13    /     double-knock-
out mice failed to develop ozone-induced AHR. (B) Total and differential 
cell counts were evaluated in BAL fl  uid. IL-4     /   /IL-13    /     double-knockout 
mice failed to develop ozone-induced airway infl  ammation. (C) Adoptive 
transfer of IL-4     /   /IL-13    /      i  NKT cells into J   18    /     failed to restore 
ozone-induced AHR. Results are expressed as the mean   ±   the SEM. 
P   ≤   0.05 (*) and P   ≤   0.01 (**) compared with mice exposed to air, and double-
knockout mice. These results are representative of three experiments. 
(D) IL-13     /     mice were exposed to ozone before measurement of AHR, as 
in A. AHR failed to occur in the IL-13     /     mice. (E) IL-4     /     mice were exposed 
to ozone before measurement of AHR, as in A. AHR failed to occur in the 
IL-4     /     mice.   390 OZONE-INDUCED AHR REQUIRES NKT CELLS AND IL-17 | Pichavant et al.
form of AHR was characterized by the presence of eosino-
phils and with high levels of IL-4 and -13 (  13  ). These diff  er-
ences may refl  ect the fact that the cytokine profi  le of the 
  i  NKT cells involved in these two diff  erent forms of AHR is 
distinct, with   i  NKT cells in allergen-induced AHR produc-
ing IL-4, but not IL-17, and   i  NKT cells in ozone-induced 
AHR producing IL-17 and -4 (  Fig. 3  ) and not expressing 
NK1.1 (when performed in C57BL/6 mice). Indeed, IL-17 
production by   i  NKT cells appears to be critical for ozone-
induced, but not allergen-induced, AHR because IL-17      /      
mice and WT mice treated with anti  –  IL-17 mAb failed to 
develop ozone-induced, but not allergen-induced AHR. 
Moreover, MHC class II      /      mice developed ozone-induced 
AHR, indicating that IL-17  –  producing   i  NKT cells and not 
class II MHC  –  restricted Th17 cells, which have been shown 
to critically regulate the development of autoimmune disease 
(  36  ), are required for the development of ozone-induced 
AHR. Recently, respiratory exposure to     -GalCer has been 
shown to induce IL-17 production by pulmonary NK1.1        
  i  NKT cells, associated with airway neutrophils, suggesting 
that IL-17 production by   i  NKT cells can occur in some cir-
cumstances, although the specifi  c function of these IL-17  –
  producing NK1.1          i  NKT cells in terms of AHR was not 
clear (  37  ). 
  Previous studies have provided confl  icting results regard-
ing the role of IL-17 in asthma. IL-17 is known to play an 
important role in activating T cells (  38  ), enhancing neutro-
phil accumulation, and inducing IL-6, TNF-    , and TGF-     
production, which increase airway infl  ammation (  39  ). Al-
though IL-17 (protein and mRNA) is present in the lungs of 
patients with severe asthma, along with eosinophils and neu-
trophils (  40  –  42  ), or in the lungs of mice chronically exposed 
to OVA (  43  ), other studies have indicated that IL-17 has a 
potent inhibitory role (  44  ), or that it has minimal eff  ects (  38  ), 
on allergen-induced AHR. Our results help to resolve these 
discrepancies, and suggest that IL-17 production by   i  NKT 
cells (and possibly by Th17 cells) mediates and is required for 
a specifi  c form of AHR (i.e., ozone-induced AHR associated 
with airway neutrophilia), but may have a minor role in other 
forms of AHR (i.e., allergen-induced AHR, associated pri-
marily with Th2-driven eosinophilic infl  ammation) (  44  ). 
However, it is possible that under some circumstances, when 
adaptive allergen-specifi  c Th2 responses develop in the con-
text of oxidative stress and/or exposure to ozone in a single 
individual, both IL-4  –   and IL-17  –  producing   i  NKT cells may 
be present to synergistically drive the development of lung 
infl  ammation and AHR. This is consistent with the observa-
tion that exposure to air pollution and allergens together re-
sults in severe airway infl  ammation and asthma (  45, 46  ). 
  The idea that ozone exposure leads to the activation of 
  i  NKT cells and to the development of AHR may be related 
to the observation that   i  NKT cells can exacerbate atheroscle-
rotic heart disease (  47  ). These observations together suggest 
that ozone exposure alters/oxidizes lipids that are sensed by 
  i  NKT cells, which then initiate the infl  ammation leading to 
the development of asthma or atherosclerotic heart disease. 
of   i  NKT cell activation with an anti-CD1d mAb also pre-
vented ozone-induced AHR and the recruitment of   i  NKT 
cells into the lungs. Furthermore, ozone-induced AHR was 
associated with IL-17 production by pulmonary   i  NKT, and 
neutralization of IL-17 with anti  –  IL-17 mAb or by disrup-
tion of the IL-17 gene prevented the development of ozone-
induced, but not allergen-induced, AHR. Together, these 
results demonstrate for the fi  rst time that repeated exposure 
to ozone induces the development of AHR in a process that 
requires   i  NKT cells (presumably responding to oxidized self-
lipids), as well as IL-17, but not adaptive immunity, conven-
tional Th2 cells, or eosinophils. 
  Although respiratory exposure to ozone is known to trig-
ger clinical symptoms of asthma and to induce toxic responses 
that have been studied extensively in laboratory animals and 
humans, the precise mechanisms by which ozone causes 
asthma have not been fully defi  ned. We and others have 
shown previously that a single acute exposure to ozone (2 
ppm for 3 h) results in the pulmonary expression of proin-
fl  ammatory cytokines, including TNF-    , IL-6, and IL-1, 
which play important roles in the airway infl  ammation and/
or AHR induced by such ozone exposures (  28  –  32  ). Although 
in our current studies we used repeated ozone exposure to 
maximize airway infl  ammation and   i  NKT cell recruitment 
over a brief period of time and have not yet compared our 
current model with the single acute exposure model, it is 
conceivable that these acute phase cytokines lead to the pro-
duction of chemokines that recruit   i  NKT cells, which then 
induce AHR upon subsequent ozone exposure. It is also 
known that exposure to ozone induces the generation of re-
active oxygen species, hydrogen peroxide, and aldehydes 
(from the ozonation of unsaturated fatty acids), leading to 
oxidative stress responses (  33  ). As such, polymorphisms in the 
genes that regulate intracellular levels of the antioxidant 
glutathione (  GSTM1   and   GSTP1  ) are associated with an 
increased susceptibility to respiratory symptoms related to 
ozone exposure in asthmatic children (  34  ). Disruption of the 
nuclear erythroid 2 p45-related factor 2 (Nrf 2) gene, which 
transcriptionally regulates many antioxidant genes, also leads 
to severe allergen-driven airway infl   ammation and AHR 
(  35  ), which is consistent with the observation that exposure 
to ozone and to ultrafi  ne particulates in air pollution increases 
airway infl  ammation and potentiates immune responses to 
inhaled allergens (  5  ). Thus, oxidative stress appears to play a 
role in the airway responses to both allergy and ozone. We 
now suggest that asthma associated with air pollution/oxidative 
stress shares another very important pathogenic disease mech-
anism with allergen-induced asthma, i.e., AHR that requires 
the presence of   i  NKT cells. 
  Although our data indicate that   i  NKT cells are required 
for both allergen-induced (  13  ) and ozone-induced AHR 
(  Fig. 1 A and Fig. 2 A  ), the pulmonary infl  ammation induced 
by ozone exposure is very distinct from that induced by aller-
gen. In our mouse model, ozone-induced AHR was charac-
terized by the presence of neutrophils, IL-17, and a small 
number of cells expressing IL-4, whereas the allergen-induced JEM VOL. 205, February 18, 2008 
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IL-4, FITC-conjugated IFN-    , APC-conjugated IL-10, Alexa Fluor 647  –
  conjugated IL-17, or the respective isotype control antibodies, as follows: 
FITC-conjugated rat IgG1k, APC-conjugated rat IgG2b, or Alexa Fluor 
647  –  conjugated rat IgG2a (eBioscience). Cells were collected on a BD 
Canto fl  ow cytometer (BD Biosciences) and analyzed with FlowJo 8.3.3 
software (Tree Star, Inc.). 
  Adoptive transfer of   i  NKT cells.       i  NKT cells were purifi  ed from spleno-
cytes of wild-type BALB/c or IL-4      /     /IL-13      /      double-knockout mice 
using magnetic cell sorting (MACS), as previously described (  13  ). Splenic 
  i  NKT cells were labeled with PE-conjugated CD1d-tetramer, followed by 
anti-PE microbeads (Miltenyi Biotec), and then sorted with AutoMACS ac-
cording to the manufacturer  ’  s instruction. Purity of   i  NKT cells was   >  80%. 
Purifi  ed   i  NKT cells (10  6  ) were adoptively transferred into recipient J    18      /      
mice by intravenous injection 1 d before the fi  rst exposure to ozone or air. 
  Ozone-exposure and measurement of airway responsiveness in the 
ozone model.     Mice were placed awake in individual wire mesh cages in-
side a stainless steel and Plexiglas exposure chamber and exposed to ozone 
(1 ppm) for 3 h. For room air exposure, a separate and identical exposure 
chamber was used. Details of the ozone exposure and monitoring have been 
previously described (  52  ). Exposure was repeated every other day (days 0, 2, 
and 4) to optimize airway infl  ammation and   i  NKT cell recruitment into the 
BAL fl  uid over the shortest period of time, and did not induce any weight 
changes in the mice (unpublished data). As a positive control for lung me-
chanics assessment, control mice received one intranasal injection of     -Gal-
Cer (0.5   μ  g) the day before the measurement of AHR (unpublished data). 
24 h after the last ozone (day 6) or     -GalCer exposure, mice were anesthetized 
with 50 mg/kg pentobarbital and instrumented for the measurement of 
pulmonary mechanics (BUXCO Electronics). Mice were tracheostomized, 
intubated, and mechanically ventilated at a tidal volume of 0.2 ml and a fre-
quency of 150 breath/min, as previously described (  52  ). Baseline lung resis-
tance (R  L  ) and responses to aerosolized saline (0.9% NaCl) were measured 
fi  rst, followed by responses to increasing doses (0.32 to 40 mg/ml) of aero-
solized acetyl-    -methylcholine chloride (methacholine; Sigma-Aldrich). The 
three highest values of R  L   obtained after each dose of methacholine were 
averaged to obtain the fi  nal values for each dose. 
  Induction of AHR and measurement of airway responsiveness in 
the OVA model.     To induce AHR, we sensitized BALB/c mice with 100   μ  g 
of OVA (Sigma-Aldrich) in alum administered i.p. After 8 d, mice were ex-
posed to intranasal antigen (50   μ  g OVA/d) or normal saline on 3 consecutive 
days, as previously described (  13  ). AHR was assessed on day 12. C57BL/6 
mice were sensitized with 100   μ  g of OVA adsorbed to 2 mg of an aqueous 
solution of alum i.p. on days 0 and 14, followed by 50   μ  g of OVA in 50   μ  l 
of PBS administered intranasally on days 14 and 25  –  27. Control mice re-
ceived i.p. injection of PBS and intranasal administrations of normal saline. 
AHR was assessed on day 28. 
  BAL fl  uid.     After measurement of AHR and euthanasia, the lungs were la-
vaged twice with 1 ml of PBS 2% FCS, and the fl  uid was pooled as previ-
ously described (  16  ). For some experiments, total BAL for each mouse or 
pooled BAL was stained and analyzed by fl  ow cytometry. BAL   i  NKT cell 
numbers were quantifi  ed by multiplying hemacytometer cell counts, exclud-
ing red blood cells, by the percentage of   i  NKT within a cellular gate that 
included lymphocytes, monocytes, large epithelial cells, and granulocytes 
(by forward scatter and side scatter). 
  Lung tissue.     After measurement of AHR, killing of the mice, and collec-
tion of BAL fl  uids, lungs were perfused with PBS 2% FCS, and portions of 
lung tissues were treated with collagenase type 4 (Worthington Biochemical 
Corp.). The lymphocyte-enriched fraction was collected at the 50  –  70% 
interface of Percoll gradients (GE Healthcare), and plated for 2 h with BD 
GolgiStop (BD Biosciences) before intracellular staining. 
Moreover, the role of   i  NKT cells in sensing oxidized lipids 
may explain the observation that obesity increases the risk of 
developing asthma in humans (  48  ) and in mice (  49  ). Thus, 
oxidized lipids, which may develop readily in obese individ-
uals or in obese mice, might serve as an important   “  antigen  ”   
that activates   i  NKT cells, leading to the development of 
AHR and atherosclerotic heart disease. 
  In summary, we identifi  ed novel cellular and molecular 
mechanisms (  i  NKT cells and IL-17) required for the develop-
ment of AHR induced by repeated ozone exposure. Impor-
tantly, because both ozone-induced and allergen-induced 
AHR require the presence of   i  NKT cells, these results 
strongly suggest that   i  NKT cells mediate a common unifying 
pathogenic mechanism for diverse forms of asthma. The spe-
cifi  c cytokines produced by   i  NKT cells in ozone- versus 
allergen-induced AHR are distinct, which may account for the 
diff  erent infl  ammatory cell types that accompany ozone- and 
allergen-induced AHR. Thus, ozone-induced AHR is asso-
ciated with neutrophils and IL-17, whereas allergen-induced 
AHR is associated with eosinophils, but primarily with IL-4 
and not IL-17. These results suggest that targeting   i  NKT may 
provide an important and eff  ective therapy for diverse and 
mixed forms of asthma. 
    MATERIALS AND METHODS   
  Mice.     Wild-type BALB/c ByJ and C57BL/6N mice were purchased from 
The Jackson Laboratory. CD1d      /      and J    18      /      mice (both backcrossed to 
BALB/c) were gifts from M. Grusby (Harvard School of Public Health, 
Boston, MA) (  50  ) and M. Taniguchi and T. Nakayama (Chiba University, 
Chiba, Japan) (  51  ), respectively. IL-17      /      mice on the C57BL/6 back-
ground were generated as previously described (  38  ), and were bred in our 
mouse colony. IL-13      /      and IL-4      /     /IL-13      /      double-knockout mice 
(BALB/c background) were obtained from A. McKenzie (Medical Research 
Council Laboratory of Molecular Biology, Cambridge, UK). IL-4      /      and 
MHC class II      /      mice were obtained from Jackson ImmunoResearch Labo-
ratories. Female mice were studied at approximately eight weeks of age. The 
Animal Care and Use Committee at Children  ’  s Hospital Boston and Harvard 
Medical School approved all animal protocols. 
  Antibodies and reagents.         -GalCer was synthesized by P.B. Savage 
(Brigham Young University, Provo, Utah), and it was used as positive con-
trol to induce AHR (unpublished data). Neutralizing rat anti  –  mouse CD1.1 
(CD1d) mAb (hybridoma HB323; American Type Culture Collection) was 
used as previously described (  16  ). Anti  –  mouse IL-17A blocking antibody 
(clone eBioTC11-18H10.1) and the control rat IgG1k isotype control anti-
body (eBioscience) were used in the blocking experiments. 
  ELISA.     Supernatants of lung cell suspensions were collected 48 h after 
    -GalCer restimulation (100 ng/ml). Mouse IL-4 and IFN-     levels were 
measured by ELISA, as previously described (  13  ). 
  Flow cytometry.     Cells were preincubated with anti-Fc     blocking mAb 
(2.4G2) and washed before staining. Cells were stained with anti  –  mouse 
FITC NK1.1, PE-Texas red  –  conjugated CD45, PerCPCy5.5-conjugated 
CD3, and Alexa Fluor 750  –  conjugated CD4 mAb (clone RM4-5).   i  NKT 
cells were identifi  ed using APC-conjugated TCR     (clone H57-597; eBio-
science) and PE-conjugated, PBS57-loaded, CD1d-tetramers (with empty 
CD1d tetramers always used as control; National Institute of Allergy and 
Infectious Disease Major Histocompatibility Complex Tetramer Core Facility, 
Atlanta, GA). For intracellular staining, after permeabilization (Cytofi  x/
Cytoperm kit; BD Biosciences), cells were incubated with FITC-conjugated 392 OZONE-INDUCED AHR REQUIRES NKT CELLS AND IL-17 | Pichavant et al.
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